The use of the drug Xavron (Edaravon) in the complex treatment of patients with ischemic stroke in combination with thrombolytic therapy

The use of the drug Xavron (Edaravon) in the complex treatment of patients with ischemic stroke in combination with thrombolytic therapy

Resume. The article describes the experience of the early use of Xavron (Edaravon) in patients with ischemic stroke in combination with thrombolytic therapy (TLT). These studies indicate greater efficacy of using Edaravon in combination with TLT in the treatment of ischemic stroke. When using the drug Xavron side effects of the drug was not observed.

Keywords:comprehensive treatment;edaravone
Authors: O.B. Leskiv, T.F. Khabaznia
Published: THE JOURNAL OF NEUROSCIENCE of B.M. Mankovskyi’ 2019, ТОМ 7, № 3-4